HOCPY
Price
$130.54
Change
-$3.79 (-2.82%)
Updated
Aug 14 closing price
Capitalization
44.65B
81 days until earnings call
ISRG
Price
$479.37
Change
+$2.28 (+0.48%)
Updated
Aug 15, 01:47 PM (EDT)
Capitalization
171.02B
62 days until earnings call
Interact to see
Advertisement

HOCPY vs ISRG

Header iconHOCPY vs ISRG Comparison
Open Charts HOCPY vs ISRGBanner chart's image
Hoya
Price$130.54
Change-$3.79 (-2.82%)
Volume$25.06K
Capitalization44.65B
Intuitive Surgical
Price$479.37
Change+$2.28 (+0.48%)
Volume$500
Capitalization171.02B
HOCPY vs ISRG Comparison Chart in %
Loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOCPY vs. ISRG commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOCPY is a Buy and ISRG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (HOCPY: $130.54 vs. ISRG: $477.08)
Brand notoriety: HOCPY: Not notable vs. ISRG: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HOCPY: 99% vs. ISRG: 102%
Market capitalization -- HOCPY: $44.65B vs. ISRG: $171.02B
HOCPY [@Pharmaceuticals: Other] is valued at $44.65B. ISRG’s [@Pharmaceuticals: Other] market capitalization is $171.02B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $171.02B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOCPY’s FA Score shows that 0 FA rating(s) are green whileISRG’s FA Score has 1 green FA rating(s).

  • HOCPY’s FA Score: 0 green, 5 red.
  • ISRG’s FA Score: 1 green, 4 red.
According to our system of comparison, ISRG is a better buy in the long-term than HOCPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOCPY’s TA Score shows that 7 TA indicator(s) are bullish while ISRG’s TA Score has 5 bullish TA indicator(s).

  • HOCPY’s TA Score: 7 bullish, 3 bearish.
  • ISRG’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HOCPY is a better buy in the short-term than ISRG.

Price Growth

HOCPY (@Pharmaceuticals: Other) experienced а +2.78% price change this week, while ISRG (@Pharmaceuticals: Other) price change was +1.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.22%. For the same industry, the average monthly price growth was -0.60%, and the average quarterly price growth was +3.83%.

Reported Earning Dates

HOCPY is expected to report earnings on Nov 04, 2025.

ISRG is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.22% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ISRG($171B) has a higher market cap than HOCPY($44.6B). ISRG has higher P/E ratio than HOCPY: ISRG (66.54) vs HOCPY (33.19). HOCPY YTD gains are higher at: 5.274 vs. ISRG (-8.598). HOCPY has higher annual earnings (EBITDA): 310B vs. ISRG (3.17B). HOCPY has more cash in the bank: 539B vs. ISRG (5.33B). ISRG has less debt than HOCPY: ISRG (87M) vs HOCPY (37.3B). HOCPY has higher revenues than ISRG: HOCPY (886B) vs ISRG (9.15B).
HOCPYISRGHOCPY / ISRG
Capitalization44.6B171B26%
EBITDA310B3.17B9,776%
Gain YTD5.274-8.598-61%
P/E Ratio33.1966.5450%
Revenue886B9.15B9,688%
Total Cash539B5.33B10,120%
Total Debt37.3B87M42,874%
FUNDAMENTALS RATINGS
HOCPY vs ISRG: Fundamental Ratings
HOCPY
ISRG
OUTLOOK RATING
1..100
106
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
7132
SMR RATING
1..100
9953
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
6276
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOCPY's Valuation (70) in the null industry is in the same range as ISRG (91) in the Medical Specialties industry. This means that HOCPY’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's Profit vs Risk Rating (32) in the Medical Specialties industry is somewhat better than the same rating for HOCPY (71) in the null industry. This means that ISRG’s stock grew somewhat faster than HOCPY’s over the last 12 months.

ISRG's SMR Rating (53) in the Medical Specialties industry is somewhat better than the same rating for HOCPY (99) in the null industry. This means that ISRG’s stock grew somewhat faster than HOCPY’s over the last 12 months.

HOCPY's Price Growth Rating (50) in the null industry is in the same range as ISRG (63) in the Medical Specialties industry. This means that HOCPY’s stock grew similarly to ISRG’s over the last 12 months.

HOCPY's P/E Growth Rating (62) in the null industry is in the same range as ISRG (76) in the Medical Specialties industry. This means that HOCPY’s stock grew similarly to ISRG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOCPYISRG
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 4 days ago
54%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 10 days ago
66%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 9 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
THQ16.270.16
+0.99%
abrdn Healthcare Opportunities Fund
PFF31.44-0.05
-0.16%
iShares Preferred&Income Securities ETF
SPE15.49-0.03
-0.23%
Special Opportunities Fund
BBCB45.73-0.11
-0.25%
JPMorgan BetaBuilders $ InvmGrdCorpBdETF
RSPA50.59-0.13
-0.26%
Invesco S&P 500 Eq Wght Inc Adv ETF

HOCPY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOCPY has been loosely correlated with TRUMY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HOCPY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPY
1D Price
Change %
HOCPY100%
-2.82%
TRUMY - HOCPY
47%
Loosely correlated
-1.38%
SSMXY - HOCPY
42%
Loosely correlated
-2.97%
ISRG - HOCPY
38%
Loosely correlated
-1.09%
OLYMY - HOCPY
36%
Loosely correlated
-0.21%
SMTI - HOCPY
34%
Loosely correlated
-4.76%
More

ISRG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISRG
1D Price
Change %
ISRG100%
-1.09%
BSX - ISRG
73%
Closely correlated
+1.61%
SYK - ISRG
64%
Loosely correlated
-0.11%
NTRA - ISRG
54%
Loosely correlated
+0.47%
MMSI - ISRG
51%
Loosely correlated
-1.08%
GKOS - ISRG
51%
Loosely correlated
-0.77%
More